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Abstract Post-translational histone modifications play a
critical role in genome functions such as epigenetic gene
regulation and genome maintenance. The tail of the
histone H4 N-terminus contains several amino acids that
can be acetylated and methylated. Some of these modi-
fications are known to undergo drastic changes during
the cell cycle. In this study, we generated a panel of
mouse monoclonal antibodies against histone H4 modi-
fications, including acetylation at K5, K8, K12, and K16,
and different levels of methylation at K20. Their speci-
ficity was evaluated by ELISA and immunoblotting
using synthetic peptide and recombinant proteins that
harbor specific modifications or amino acid substitutions.
Immunofluorescence confirmed the characteristic distri-
butions of target modifications. An H4K5 acetylation
(H4K5ac)-specific antibody CMA405 reacted with
K5ac only when the neighboring K8 was unacetylated.
This unique feature allowed us to detect newly assembled
H4, which is diacetylated at K5 and K12, and distinguish
it from hyperacetylated H4, where K5 and K8 are both
acetylated. Chromatin immunoprecipiation combined
with deep sequencing (ChIP-seq) revealed that acetyla-
tion of both H4K8 and H4K16 were enriched around
transcription start sites. These extensively characterized
and highly specific antibodies will be useful for future
epigenetics and epigenome studies.
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TSSs Transcription start sites
Introduction
In eukaryotic nuclei, ∼150 bp of DNA is wrapped
around the histone octamer, which consists of two cop-
ies of four core histones (i.e., H2A, H2B, H3, and H4) to
form a nucleosome, the fundamental unit of chromatin.
Post-translational modifications on these histones play a
critical role in genome function, including the regulation
of transcription and the maintenance of genome integri-
ty (Bannister and Kouzarides 2011; Greer and Shi 2012;
The ENCODE Project Consortium 2012; Jørgensen
et al. 2013). Since H3 and H4 are more stably integrated
into nucleosomes compared to H2A and H2B (Kimura
and Cook 2001), the modifications on H3 and H4 can
act as long-term memory of epigenetic regulation.
Among various H3 modifications, trimethylation on
H3 lysine 9 and 27 (H3K9me3 and H3K27me3) that is
associated with silenced genes can be inherited over cell
generations (Martin and Zhang 2005; Greer and Shi
2012; Kimura 2013). Other modifications, such as
trimethylation on H3 lysine 4 (H3K4me3) and acetyla-
tion are associated with transcriptional activation
(Heintzman et al. 2007; Shilatifard 2008; Stasevich
et al. 2014). Modifications on histone H4 are also
known to be involved in gene regulation and genome
maintenance (Shahbazian and Grunstein 2007). Lysine
residues in H4 N-terminal tail (i.e., H4K5, H4K8,
H4K12, and H4K16) are major acetylation sites
(Turner et al. 1989; Johnson et al. 1998; Lang et al.
2013; Taylor et al. 2013; Zheng et al. 2013). These
acetylations are predominantly associated with euchro-
matin, contributing to chromatin decondensation and
transcriptional regulation (Turner 1991; Dion et al.
2005; Wang et al. 2008; Bannister and Kouzarides
2011). H4K16ac is also known to be associated with
DNA damage repair and cell senescence (Dang et al.
2009; Li et al. 2010; Sharma et al. 2010; Krishnan et al.
2011). In addition, H4K5ac and H4K12ac are associated
with newly assembled chromatin since H4 in
predeposition complexes is diacetylated at K5 and
K12 by a histone acetyltransferase (HAT) (Sobel et al.
1995; Chang et al. 1997). Although the diacetylation of
H4 is not a prerequisite for histone assembly (Ma et al.
1998), these modifications may stimulate nuclear import
(Ejlassi-Lassallette et al. 2011) and contribute to the
recovery from replication block-mediated DNA damage
(Barman et al. 2006). After being assembled into chro-
matin, H4 becomes deacetylated in heterochromatin
(Taddei et al. 1999). In contrast to these four lysines that
are acetylated, H4 lysine 20 (H4K20) is subject to
methylation (Jørgensen et al. 2013). Monomethylation
of H4K20 (H4K20me1) may play multiple roles in
genome regulation, including transcriptional control,
DNA replication licensing, DNA damage response,
and chromosome segregation (Wu and Rice 2011;
Beck et al. 2012; Kapoor-Vazirani and Vertino 2014).
Dimethylation of H4K20 (H4K20me2) is one of the
most abundant modifications in mouse fibroblasts and
HeLa cells (Pesavento et al. 2008; Schotta et al. 2008),
and is involved in DNA damage repair signaling
(Greeson et al. 2008).
Trimethylation on H4 lysine 20 (H4K20me3) is also
involved in heterochromatin formation, correlated with
H3K9me3 (Schotta et al. 2004; Sims et al. 2006). The
levels of some histone H4 modifications, like H4K16ac
and H4K20me3, are reported to be altered in cancer
cells, suggesting these marks can possibly be diagnostic
markers (Fraga et al. 2005; Ellis et al. 2009; Rodriguez-
Paredes and Esteller 2011; Yokoyama et al. 2014).
To analyze histone modifications, specific antibodies
have been valuable tools with a variety of applications,
such as chromatin immunoprecipitation, immunoblot-
ting detection, and immunofluorescence (Turner et al.
1992; Peters et al. 2003; Kimura et al. 2008). The
quality and reproducibility of these immunochemical
analyses rely on antibody specificity and affinity, but
commercially available antibodies have not been vali-
dated extensively (Clayton et al. 2006; Kimura et al.
2008; Rothbart et al. 2012; Kimura 2013). For example,
20–25 % of histone modification-specific antibodies
failed to pass the validation by the ENCODE project
(Egelhofer et al. 2011). To facilitate chromatin and
epigenetics studies, we have developed histone H3
modification-specific antibodies (Kimura et al 2008;
Hayashi-Takanaka et al. 2009, 2011, 2014; Chandra
et al. 2012). We here report the generation and valida-
tion of a panel of monoclonal antibodies (mAbs) direct-
ed against histone H4. These highly reliable and fully
characterized mAbs will be useful for future work.
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Materials and methods
Ethics statement
All institutional and national guidelines for the care and
use of laboratory animals were followed. All animal
care and experimental procedures in this study were
approved by the Hokkaido University Animal
Experiment Committee (approval number: 11-0109)
and carried out according to guidelines for animal ex-
perimentation at Hokkaido University, where Mab
Institute Inc is located. Animals were housed in a spe-
cific pathogen-free facility at Hokkaido University.
Humane euthanasia of mice was performed by cervical
dislocation by individuals with a demonstrated high
degree of technical proficiency.
Generation, selection, purification, and dye conjugation
of monoclonal antibodies
Synthetic peptides (Sigma-Genosys; Fig. 1) were
coupled to keyhole limpet hemocyanin and used to
immunize mice (Kimura et al. 1994); after generating
hybridomas, clones were screened by ELISA using
plates coated with the modified or unmodified peptide
conjugated with bovine serum albumin. After recloning,
supernatants from clones reacting with the specifically
modified peptide were used to probe blots prepared
using HeLa total proteins, and the ones giving a single
band at the size of histone H4 were selected for immu-
nofluorescence examination to see if they exhibited
nuclear staining. Clones that passed through these suc-
cessive screens were further analyzed by ELISA against
peptides listed in Fig. 1, and the ones showing the
highest specificity to the authentic peptides were select-
ed. The isotype of each mAb was determined using a kit
(Serotec; MMT1; Table 1).
Hybridoma cells were routinely grown in GIT medi-
um (Wako). For antibody purification, cells were grown
in CD Hybridoma medium (Life Technologies) and the
supernatant (250 ml) was filtrated through a 0.45-μm
pore filter, as previously described (Hayashi-Takanaka
et al. 2011). For IgG1 subclass mAbs, NaCl was added
at a final concentration of 4 M before applying to a
HiTrap Protein A HP Sepharose column (1 ml; GE
Healthcare), which were pre-equilibrated with Protein
A IgG1 binding buffer (Thermo Fisher Scientific). After
washing the column with Protein A IgG1 binding buff-
er, IgG1 was eluted using Mouse IgG1 Mild Elution
Buffer (Thermo Fisher Scientific). For IgG2b mAbs, the
filtrated supernatant was directly loaded to a HiTrap
Protein A HP Sepharose column (1 ml; GE
Healthcare) pre-equilibrated with phosphate-buffered
saline (PBS). After washing with PBS, IgG was eluted
using IgG Elution buffer (Thermo Fisher Scientific) and
the buffer pH was immediately neutralized using 1.5 M
Tris–HCl (pH 8.8). IgG was concentrated up to
∼2 mg/ml in PBS using an Amicon Ultra filter (50 k-
cut off; Millipore).
Purified IgG was conjugated with a fluorescent dye
(Hayashi-Takanaka et al. 2014). Dried Alexa Fluor 488
5 -SDP es t e r ( 1 mg ; Inv i t r ogen ) , Cy3 N -
hydroxysuccinimide ester (for labeling 1 mg protein;
GE Healthcare), and Cy5 N-hydroxysuccinimide ester
(for labeling 1 mg protein; GE Healthcare) were dis-
solved into 100 μl dimethyl sulfoxide (DMSO; Wako)
and stored at −20 °C. IgG (100 μg) was diluted into
100 mM NaHCO3 (pH 8.3) in 100 μl. After addition of
a dye solution (1, 1.5, and 4 μl for Alexa488, Cy3, and
Cy5, respectively), the mixture was incubated for 1 h at
room temperature with gentle rotation. The sample was
passed through a PD-mini G-25 desalting column (GE
Healthcare), which was pre-equilibrated with PBS, to
remove unconjugated dyes, and dye-conjugated IgG
was concentrated up to ∼1 mg/ml using an Ultrafree
0.5 filter (10 k-cut off; Millipore). The IgG concentra-
tion and dye:protein ratio were calculated from the
absorbance at 280 and 494, 552, or 650 nm, using the
extinction coefficient of IgG and correction factor at
280 nm provided by the manufacturers. Fluorescent
dye-labeled IgG samples that yielded dye:protein ratio
∼3–9 were used for live imaging.
Cells
hTERT-RPE1 (purchased from Clontech; September
22, 1999; the pseudodiploid karyotype occasionally
checked with most recently in February 2015) and
HeLa cells (obtained from Peter Cook; ref. Pombo
et al. 1999) were grown in Dulbecco’s Modified
Eagle’s medium (DMEM; Nacalai Tesque) supplement-
ed with L-glutamine/penicillin/streptomycin (2 mM L-
glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomy-
cin; Sigma-Aldrich) and 10 % fetal calf serum (FCS), as
previously described (Hayashi-Takanaka et al. 2009).
For ChIP experiments, mouse embryonic stem cells
(ZHBTc4 cell line) were obtained from RIKEN BRC
on January 11, 2011 (Niwa et al. 2000). Cells were
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maintained on culture dishes coated with 0.1 % type-A
gelatin (Sigma-Aldrich) in Glasgow Minimum
Essential Medium (Sigma-Aldrich) supplemented with
10 % fetal bovine serum (Equitech-Bio, Kerrville,
TX), 1× nonessential amino acids (Nacalai Tesque),
1 mM sodium pyruvate (Nacalai Tesque), 0.1 mM 2-
mercaptoethanol (Nacalai Tesque), and 2000 U/ml
Murine LIF.
Immunoblotting
Acetylated H4 tagged with NHis was produced by an
in vitro translation system and purified as described
(Mukai et al. 2011). Methylation mimic histones were
purchased (Active Motif). HeLa histones were purified
using the Histone Purification mini kit (Active Motif). H4
proteins (100 and 10 ng for Coomassiee-staining and
immunoblotting, respectively) were separated in 15 %
SDS-polyacrylamide gels (Wako), and either stained with
Coomassiee Brilliant Blue (Wako) or transferred onto
PVDF membranes (Pall) for immunoblotting using a
semi-dry system (ATTO; 192 mM glycine, 100 mM
Tris, and 5 %methanol; 70 min). PVDFmembranes were
washed with TBST (20 mM Tris–HCl (pH 8.0), 150 mM
NaCl, and 0.05 % Tween 20), blocked with Blocking
One-P (Nacalai Tesque) for 20 min, and incubated in
mAbs (0.1–0.2 μg/ml) in TBST containing 10 %
Blocking One-P for 1 h. After washing with TBST four
times over 30 min, membranes were incubated in
peroxidase-conjugated anti-mouse IgG (GE Healthcare;
1:1,000 in TBST) for 1 h, washed with TBST four times

































































Fig. 1 Specificity of mAbs evaluated by ELISA. Microtiter plates
coated with the indicated peptides conjugated with bovine serum
albumin were incubated with threefold dilutions of each antibody,
starting from 1:100 dilution of a hybridoma culture supernatant.
After incubation with peroxidase-conjugated secondary antibody
and washing, the colorimetric signal of tetramethylbenzidine was
detected by measuring the absorbance at 405 nm using a plate
reader. The peptides reacted with the individual mAb are indicated
on the panel
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(Perkin-Elmer). Chemiluminescent signals were captured
using a LAS-3000 (Fuji film).
Expression vectors for lysine-to-alanine substitution
mutants were constructed based on pBOS-H4-N-GFP
(Kimura and Cook 2001) using a Quickchange kit
(Stratagene) with specific primers containing single mu-
tations. The resulting constructs were verified by nucle-
otide sequencing. HeLa cells grown on a 60-mm dish
were transfected with plasmid DNA (2 μg) using
Lipofectamine 2000 (Life Technologies; 10 μl) and
further grown for a day. Cells were lysed using 2×
SDS-gel loading buffer (0.5 ml) and boiling for 5 min,
and 5 μl of lysate was separated in 10–20 % SDS-
polyacrylamide gels (Wako) for immunoblotting.
Immunofluorescence
Cells were fixed, permeabilized, and blocked as described
previously (Kimura et al. 2006; Hayashi-Takanaka et al.
2009). To label replication foci, cells were incubated in
10 μM EdU for 7.5 min before fixation, and the signal
was detected with Alexa Fluor 647 azide using a Click-iT
EdU Imaging Kit (Life Technologies).
Cells were then incubated in labeled mAbs (0.2–
1 μg/ml) with Hoechst 33342 (100 ng/ml in PBS) in
PBS containing 10 % Blocking One-P (Nacalai Tesque)
for 2 h at room temperature. After washing with PBS,
coverslips were mounted in Prolong Gold (Life
Technologies). Fluorescence images were collected using
a confocal microscope (FV-1000; Olympus) operated by
the built-in software (ver 2.1-4.1) with a PlanSApo 60×
(NA=1.35) or a PlanApoN SC 60× (NA=1.4) objective
lens (512×512 pixels; 12.5 μs/pixel; 4 line Kalman; 12-
bit; pinhole 110μm). Hoechst 33342, Alexa488, Cy3, and
Cy5/Alexa647 signals were acquired by sequential scan-
ning using laser lines at 405, 488, 543, and 633 nm,
combined with emission dichroic mirror/barrier filter
SDM490/BA430-470, SDM560/BA505-525, SDM640/
BA560-620, and none/BA650IF, respectively, with a
main dichroic mirror DM405/488/543/633.
ChIP
Cells (ZHBTc4) were cross-linked in 0.5 % formalde-
hyde and suspended in 250 μl ChIP buffer (5 mM
PIPES (pH 8.0), 200 mM KCl, 1 mM CaCl2, 1.5 mM
MgCl2, 5 % sucrose, 0.5 % NP-40, and protease inhib-
itor cocktail; Nacalai Tesque). Samples were incubated
for 15 min on ice, sonicated for 5 s three times, and
digested with micrococcal nuclease (1 μl; New England
Biolabs) and Ribonuclease A (1 μl; Nacalai Tesque) at
37 °C for 40 min. The digested samples were centri-
fuged at 15,000×g for 10 min. Supernatant containing
4–8 μg DNAwas incubated with a mouse monoclonal
antibody against H4K5ac, H4K8ac, H4K12ac, or
H4K16ac, pre-bound to magnetic beads at 4 °C over-
night with rotation. The immune complexes were
washed twice with ChIP buffer and twice with TE
buffer. After, cross-links were reversed by incubating
in TE containing 1 % SDS at 65 °C overnight with
Table 1 Summary of monoclonal antibodies








K5 Acetyl IgG1-κ K8-acetyl
CMA408
(200Nd 72A9)













K20 Monomethyl IgG1-κ K16-acetyl
CMA422
(200c 2E2)
K20 Dimethyl IgG1-κ K16-acetyl
CMA423
(200d 27F10)
K20 Trimethyl IgG1-κ K16-acetyl
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proteinase K, and DNAwas purified using a QIAquick
PCR purification kit (Qiagen).
ChIP-seq data analysis
Sequenced reads of chromatin immunoprecipiation
combined with deep sequencing (ChIP-seq) data were
mapped onto the mouse genome (mm9) with Bowtie
(version 0.12.8) using the parameter B-n 3 -m 2^.
Estimation of normalized ChIP-seq signal intensities were
calculated as follows. First, we counted mapped reads at
10,000 bp (Fig. 4a, b), 200 bp (Fig. 4c), or 100,000 bp
(Fig. 4d) intervals (bins) on the genome. The counts were
normalized as RPKM (reads per kilobase per million
mapped reads) (Mortazavi et al. 2008). Net ChIP-seq
signal intensities were obtained by subtracting the input
RPKM in each bin (Accession number, DRA002438 for
H4 acetylation data; and SRX185820 for H3K7ac data).
mRNA-seq and data analysis
Sequencing was performed using a Genome Analyzer
IIx (Illumina). PolyA+ RNAwas enriched from 100 ng
of total RNA by two successive rounds of oligo(dT)
selection. The polyA+ RNA was fragmented and first-
strand cDNA was synthesized by random hexamer
priming. Following second-strand cDNA synthesis,
dsDNA was repaired using T4 DNA polymerase,
Klenow enzyme, and T4 polynucleotide kinase (PNK)
(New England Biolabs), followed by treatment with
Klenow exo- to add an A base to the 3′ end. After
ligation of the adaptor using TaKaRa Ligation Mix
(TaKaRa), the adaptor-ligated DNAwas amplified using
PCR primers for 12 cycles, and the amplified library
was isolated using the E-gel Electrophoresis System
(Life Technologies). The samples were purified using
a QIAquick MinElute Kit (Qiagen). Sequenced reads
were mapped onto the mouse genome (mm9) using
Tophat (version 2.0.10). Gene expression levels
(FPKM; Fragments per kilobase of exon per million
mapped sequence reads) were estimated by Cufflinks
(version 2.1.1) using the parameters B-u -b (on
cuffdiff)^. We classified genes into 11 groups based on
the expression levels: Silent (FPKM=0) and 10 groups
with different expression levels separated at 10 percen-
tile intervals (q0–10 %, q10–20 %, … and q90–100 %
of genes from the lowest to the highest FPKM).
For a close look at ChIP-seq results, IGV_2.0.34 was
used, as in Fig.4a, b.
Results and discussion
Generation of mAbs directed against modified histone
H4
We generated mAbs directed against unmodified and
specifically modified forms of histone H4, including
acetylation at K5, K8, K12, and K16, and three levels
of methylation at K20 (Table 1). The specificity was
evaluated by ELISA and immunoblotting using synthet-
ic peptides and recombinant proteins, respectively.
Pan-H4 antibody for immunoblotting
mAb CMA400 reacted with all peptides containing
amino acid 11–29 of H4, regardless of modifications at
K16 and K20, but not with those containing amino acid
1-19 (Fig. 1). This indicates that CMA400 recognizes
the peptide sequence between amino acid 21 and 29.
Consistently, immunoblotting showed that CMA400
reacts with all recombinant H4 proteins harboring acet-
ylation at K5, K8, K12, K16, and K20, and methylation
mimic modifications at K20 as well as H4 prepared
from HeLa cells (Fig. 2a). Therefore, CMA400 appears
to be useful as a pan-H4 mAb by immunoblotting.
CMA400, however, failed to stain cell nuclei by immu-
nofluorescence, possibly because the epitope region is
masked due to the direct interaction between the H4 tail
in a nucleosome and H2A in another nucleosome (Luger
et al. 1997; Sinha and Shogren-Knaak 2010).
Acetylation-specific antibodies
ELISA and immunoblotting also revealed that
modification-specific mAbs reacted exclusively with
the corresponding peptides and recombinant H4 harbor-
ing the target modifications (Figs. 1 and 2). For example,
CMA416 reacted with all peptides containing K16ac,
regardless of the neighboring modifications such as
K12ac, K20ac, and K20me1-3 by ELISA (Fig. 1). The
specific binding of CMA416 to H4K16ac was confirmed
by immunoblotting using recombinant H4; it highlighted
H4 proteins harboring K16 acetylation and K5/K8/K12/
K16 tetra-acetylation (Fig. 2a). In addition to the endog-
enous H4, exogenously expressed GFP-tagged H4 and
mutant proteins, except H4K16A, were detected by
CMA416 (Fig. 2b), indicating that H4K16 is required
for CMA416 binding. From these data, it is concluded
that CMA416 specifically binds to H4K16ac. Similarly,
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CMA408 and CMA412 specifically reacted with
H4K8ac and H4K12ac, respectively, regardless of the
neighboring modifications (Figs. 1 and 2).
Interestingly, CMA405 was specific to H4K5ac com-
bined with unmodified K8, distinguishable from
diacetylated H4 at K5 and K8 (Figs. 1 and 2). In ELISA,
CMA405 reacted with monoacetylated peptide at K5 but
not with diacetylated peptide at K5 and K8 (Fig. 1).
Immunoblotting also showed that CMA405 exclusively
reacted with K5-acetylated H4, but not with tetraacetylated
H4 at K5/K8/K12/K16 (Fig. 2a), or H4K8A and H4K5A
mutants (Fig. 2b). These results indicate that both acetylat-
ed K5 and unacetylated K8 are required for CMA405
binding. In Fig. 2b, CMA405 reacted more with
H4K12A and H4K20A mutants, suggesting that
CMA405 reactivity depends on these residues. To examine
whether K12 acetylation influences the antibody recogni-
tion, we used recombinant histoneH4 that harbors bothK5
and K12 acetylation. As shown in Fig. 2c, CMA405
reacted equally with K5-acetylated and K5/K12-
diacetylated H4, but not with K5/K8-diacetylated and
K12-acetylated H4, indicating that CMA405 reactivity is
not affected by K12 modification state. The differential
reactivity to transiently expressed H4K12A mutant can be
explained by the interplay between the modifications of
different residues in living cells, as also observed in
H4K12 acetylation (Fig. 2b; CMA412 blot) and in a
previous study (Sasaki et al. 2009).
The unique characteristic of CMA405 appeared to
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Fig. 2 Specificity of mAbs evaluated by immunoblotting. amAb
reactivity to recombinant and HeLa histone H4. NHis-tagged H4,
NHis-tagged acetylated H4 (monoacetylated or tetraacetylated at
K5/K8/K12/K16 [tetra-ac]), H4, methyl-mimic H4, and HeLa
histones were separated in 15 % SDS-polyacrylamide gels and
stained with Coomassiee Brilliant Blue (top panel) or probed with
the indicated mAbs (lower panels). The positions of size standards
are indicated on the left of the top panel. bmAb reactivity to GFP-
H4 mutants. GFP-H4 (wild-type; wt) and lysine-to-alanine (KA)
mutants were expressed in HeLa cells. Total protein was separated
in 10–20 % SDS-polyacrylamide gel and probed with the
indicated mAbs. The top panel with anti-H4K16ac mAb
CMA416 shows a typical example. Both the endogenous H4 and
GFP-tagged H4 and KA mutants except K16A are detected with
CMA416. The positions of size standards are indicated on the
right. The membrane was reprobed using GFP-specific antibody
(second panel). Relevant parts are shown for other mAbs (lower
panels). c CMA405 reactivity to recombinant histone H4. NHis-
tagged H4 proteins were separated in 15 % SDS-polyacrylamide
gels and stained with Coomassiee Brilliant Blue (top panel) or
probed with CMA405 (bottom panel). The positions of size
standards are indicated on the right
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diacetylated at K5 and K12 (with unacetylated K8) over
the hyperacetylated H4, which harbors acetylation on
K5, K8, K12, and K16. Indeed, immnofluorescence
revealed that only a fraction of cells were intensely
stained with CMA405, and the intra-nuclear distribution
resembled replication foci in S phase cells (Fig. 3a). To
compare the distribution of CMA405 with replication
foci, cells were pulse-labeled with ethynyl-deoxyuridine
(EdU) for 7.5 min, fixed, and stained with Alexa Fluor
647-azide and CMA405. As shown in Fig 3a, CMA405
overlapped with Alexa647-labeled EdU, confirming
that CMA405 detected newly assembled histone H4 that
harbor K5 acetylation. CMA412 was also enriched in
replication foci but still remained in euchromatin where
the signal did not overlap with Hoechst (Fig. 3b). This is
explained by the specificity of CMA412, which reacted
with H4K12ac regardless of the neighboring K8 and
K16 acetylation (Fig. 1). CMA412 could detect both
newly assembled H4, which harbors acetylated K12
with unacetylated K8 and K16, and euchromatin-
associated H4, which harbors acetylation at K8 and/or
K16 together with K12. Immunofluorescence further
revealed that CMA408 and CMA416 showed a euchro-
matin distribution, consistent with a role of H4K8 and
H4K16 acetylation in chromatin decondensation and
transcriptional activation (Fig. 3c, d).
ChIP-seq with acetylation-specific antibodies
To reveal the localization of acetylation at different
lysines in H4, we performed ChIP-seq analysis using
mouse embryonic stem cells with the specific antibod-
ies. In a genome-wide view, H4K5ac was not enriched
in specific loci, but was rather depleted from transcrip-
tionally active regions, complementary to H4K8ac and
H4K16ac (Fig. 4a, b). Aggregation plots confirmed that
H4K5ac with unacetylated K8 (detected by CMA405)
was excluded from transcription start sites (TSSs) of
actively transcribed genes (Fig. 4c). This depletion in
highly expressed genes probably reflects the absence of
nuc leosomes a t TSSs and the presence of
hyperacetylated H4, in which K5 and K8 are both
acetylated, around TSSs. H4K12ac (detected by
CMA412) was distributed similarly to H4K5ac, but
slightly enriched in upstream and downstream regions
from TSSs in expressed genes. This is consistent with
the property of the antibody, which binds to H4K12ac
regardless of acetylation at K8 and K16, and detects
both replication-associated and euchromatin-associated
H4K12ac. H4K8ac and H4K16ac (detected by
CMA408 and CMA416, respectively) were enriched
around the TSS of highly expressed genes like
H3K27ac, but their distributions were broader and
slightly more distant from the TSS than H3K27ac.
Correlation analysis also indicated the high similarity
between H4K8ac and H4K16ac (Fig. 4d). H3K27ac and
H4K8ac, or H4K16ac, were also correlated, but not as
much as the correlation between H4K8ac and H4K16ac,
in good agreement with the aggregation plots (Fig. 4c).
Little correlation was observed between H4K5ac and
H4K8ac, consistent with their apparently distinct distri-
butions by genome browser and aggregation plots.
Methylation-specific antibodies
Among the H4K20 methylation-specific mAbs,
H4K20me1- and H4K20me3-specific mAbs (CMA421
and CMA423) reacted with their targets in the presence of
K16ac, and H4K20me2-specific CMA422 hardly reacted
with the peptide containing K16ac with K20me2 (Fig. 1).
Immunoblotting showed these antibodies reacted specifi-
cally with the corresponding methylation mimic H4 pro-
teins (Fig. 2). The specificity of each mAb to the target
modification was also confirmed by their characteristic
immunofluorescence patterns. hTERT-RPE1 cells stained
with CMA421 showed heterogeneity in signal intensity
(Fig. 5a), in good agreement with the previous report
showing that H4K20me1 level increases during G2 to M
phase (Rice et al. 2002; Pesavento et al. 2008). Indeed,
interphase cells positive in H3S10 phosphorylation, which
begins to appear in late S through G2, were often heavily
stained with CMA421 (Fig. 5a). Thus, double staining
cells with CMA405 (to detect S phase) and CMA421 (to
detect G2 phase) was able to identify the cell cycle stage
of individual cells (Fig. 5a). Furthermore, inactive X
chromosomes were highlighted with CMA421 in
hTERT-RPE1 cells (Fig. 5b), as shown previously.
CMA422 and CMA423 exhibited DAPI-like and hetero-
chromatin patterns, respectively, again consistent with
previous observations (Fig. 5c, d).
Conclusions
We showed that mouse mAbs directed against histone H4
and its modifications are highly specific to the targets and
are applicable to immunoblotting, immunofluorescence,
and ChIP-seq. While histone modification-specific
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antibodies are now widely available from different ven-
dors, most of them are rabbit polyclonals and therefore
associated with lot-to-lot variation of the specificity and












H4K12acHoechst H4K5ac merge H4K12acHoechst H4K5ac merge
Fig. 3 Localization of acetylation-specific mAbs. HeLa cells were
fixed and immunolabeled with mAbs conjugated with Alexa Fluor
488 and Cy3. DNA was counterstained with Hoechst 33342.
Shown are single confocal sections. a To label replication foci,
cells were incubatedwith EdU for 7.5min before fixation. EdUwas
detected with Alexa Fluor 647-azide before immunolabeling with
H4K5-specific CMA405 conjugated with Alexa488. CMA405
overlaps with EdU (replication) foci in S phase cells. b H4K12ac-
specific CMA412 (Alexa488) generally distributes in euchromatin
and also enriched in CMA405 (Cy3) foci. c H4K8ac-specific
CMA408 (Alexa488) is enriched in euchromatin. d H4K16ac-
specific CMA416 (Alexa488) is enriched in euchromatin. Bars,
10 μm
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25 % of histone modification-specific antibodies were
disqualified for ChIP-seq application (Egelhofer et al.
2011). As the property of mAb remains constant over
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Fig. 4 Localization of acetylated H4 in mouse ES cells by ChIP-
seq. Genome-wide distribution of acetylated H4 was analyzed by
ChIP-seq using CMA405, CMA408, CMA412, and CMA416. a
Snapshot of the enrichment in whole chromosome 2. b Snapshot of
the enrichment in chromosome 2 with a narrow view field. c
Aggregation plots. Normalized peak counts of H4K5ac, H4K8ac,
H4K12ac, H4K16ac, and H3K27ac signals surrounding the tran-
scription start site (TSS) are indicated for 11 groups of genes which
were divided based on their gene expression. d Correlation among
histone H4K5, K8, K16, and H3K27ac modifications. H4K8ac,
K16, and H3K27ac have positive correlation but not with H4K5ac
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for future epigenetics and epigenome studies. In fact,
some of these antibodies have already proven useful for
immunofluorescence withmouse tissue sections (Eberhart
et al 2012, 2013), histochemistry with human patient
specimen (Yokoyama et al 2014; Shinchi et al 2015),
and ChIP-seq using chicken DT40 cells (Hori et al 2014).
Among the mAbs described here, H4K5ac-specific
mAb CMA405 has a unique specificity. It recognizes
acetylated K5 with unacetylated K8. This combination
is typically found in newly assembled H4, which is
diacetylated at K5 and K12, and CMA405 indeed high-
lights structures that resemble DNA replication foci in S
phase cells. Thus, CMA405 will be particularly useful
for detecting newly assembled chromatin and also for
highlighting cells in S phase by microscopy and flow
cytometry.
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Fig. 5 Localization of methylation-specific mAbs. hTERT-RPE1
(a, b) and HeLa (c, d) cells were fixed, immunolabeled with the
indicated mAbs conjugated with Alexa Fluor 488, Cy3, or Cy5.
DNA was counterstained with Hoechst 33342. Shown are single
confocal sections. a hTERT-RPE1 cells were stained with
H4K20me1-specific CMA421 (Alexa488), H3S10ph-specific
CMA313 (Cy3), and H4K5ac-specific CMA405 (Cy5). The cell
cycle points, judged from the staining patterns of H3S10ph and
H4K5ac, are indicated. CMA421 is enriched inG2 cells (H3S10ph-
positive; H4K5ac-negative) than cells in G1 (H3S10ph-negative;
H4K5ac-negative) and S (H3S10-negative; H4K5ac-positive).
Under the condition to detect H3S10ph signals in G2 cells, those
on mitotic chromosomes are saturated (asterisk) due to massive
phosphorylation during M phase. b hTERT-RPE1 cells were
stained with H4K20me1-specific CMA421 (Alexa488) and
H3K27me3-specific CMA323 (Cy3). CMA421 is concentrated
on inactive X chromosome indicated by H3K27me3. c HeLa cells
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